Skip to main content
Top
Published in: Journal of Gastroenterology 5/2014

01-05-2014 | Letter to the Editor

Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma

Authors: Andrea Lisotti, Francesco Azzaroli, Marco Montagnani, Alberto Porro, Giuseppe Mazzella

Published in: Journal of Gastroenterology | Issue 5/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Yamazaki S, Takayama T, Nakamura M, et al. Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol. 2013. doi:10.1007/s00535-013-0841-y (epub ahead of print). Yamazaki S, Takayama T, Nakamura M, et al. Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol. 2013. doi:10.​1007/​s00535-013-0841-y (epub ahead of print).
2.
go back to reference Lisotti A, Azzaroli F, Buonfiglioli F, et al. Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 2014;59(2):643–50. doi:10.1002/hep.26700. Lisotti A, Azzaroli F, Buonfiglioli F, et al. Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 2014;59(2):643–50. doi:10.​1002/​hep.​26700.
Metadata
Title
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma
Authors
Andrea Lisotti
Francesco Azzaroli
Marco Montagnani
Alberto Porro
Giuseppe Mazzella
Publication date
01-05-2014
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 5/2014
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-014-0935-1

Other articles of this Issue 5/2014

Journal of Gastroenterology 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.